The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic- onset juvenile chronic arthritis

Journal of Clinical Investigation

Volumn 102, Issue 7, 1998, Pages 1369-1376

  Fishman, Daniel ^a   Faulds, Gary ^b   Jeffey, Rachel ^a   Mohamed Ali, Vidya ^c   Yudkin, John S ^c   Humphries, Steve ^b   Woo, Patricia ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

Cytokine; Genetics; JCA; SSCP; Transfection

Indexed keywords

CYTOKINE; DNA; INTERLEUKIN 6;

ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0032189103     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2629     Document Type: Article

References (47)

1. Symmons, D., M. Jones, J. Osborne, J. Sills, T. Southwood, and P. Woo. 1996. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J. Rheum. 11:13-16.
2. Laxer, R., and R. Schneider. 1993. Systemic-onset juvenile chronic (rheumatoid) arthritis and adult-onset Still's disease. In Oxford Textbook of Rheumatology. P. Maddison, D. Isenberg, P. Woo, and D. Glass, editors. Oxford Medical Publications, Oxford. 722-731.
3. Wallace, C.A., and J.E. Levinson. 1991. Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. Rheum. Dis. Clin. North Am. 17:891-905.
4. Fishman, D., M. Rooney, and P. Woo. 1995. Successful management of reactive haemophagocytic syndrome in systemic-onset juvenile chronic arthritis [letter]. Br. J. Rheumatol. 34:888.
5. De Benedetti, F., M. Massa, P. Robbioni, A. Ravelli, G.R. Burgio, and A. Martini. 1991. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum. 34:1158-1163.
6. Lepore, L., M. Pennesi, S. Saletta, S. Perticarari, G. Presani, and M. Prodan. 1994. Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin. Exp. Rheumatol. 12:561-565.
7. Mangge, H., H. Kenzian, S. Gallistl, G. Neuwirth, P. Liebmann, W. Kaulfersch, F. Beaufort, W. Muntean, and K. Schauenstein. 1995. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum. 38:211-220.
8. De Benedetti, F., P. Pignatti, M. Massa, P. Sartirana, A. Ravelli, and A. Martini. 1995. Circulating levels of interleukin 1 beta and of interleukin 1 receptor antagonist in systemic juvenile chronic arthritis. Clin. Exp. Rheumatol. 13: 779-784.
9. Rooney, M., J. David, J. Symons, F. Di Giovine, H. Varsani, and P. Woo. 1995. Inflammatory cytokine responses in juvenile chronic arthritis. Br. J. Rheumatol. 34:454-460.
10. Prieur, A.M., P. Roux Lombard, and J.M. Dayer. 1996. Dynamics of fever and the cytokine network in systemic juvenile arthritis. Rev. Rhum. Engl. Ed. 63:163-170.
11. Tilg, H., E. Trehu, M.B. Atkins, C.A. Dinarello, and J.W. Mier. 1994. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 83:113-118.
12. Jordan, M., I.G. Otterness, R. Ng, A. Gessner, M. Rollinghoff, and H.U. Beuscher. 1995. Neutralization of endogenous IL-6 suppresses induction of IL-1 receptor antagonist. J. Immunol. 154:4081-4090.
13. Yoshizaki, K., T. Matsuda, N. Nishimoto, T. Kuritani, L. Taeho, K. Aozasa, T. Nakahata, H. Kawai, H. Tagoh, T. Komori, et al. 1989. Pathological significance of interleukin-6 (IL-6/BSF-2) in Castleman's Disease. Blood. 74: 1360-1367.
14. Dao, D.D., J.R. Sawyer, J. Epstein, R.G. Hoover, B. Barlogie, and G. Tricot. 1994. Deletion of the retinoblastoma gene in multiple myeloma. Leukemia. 8:1280-1284.
15. Helle, M., J. Brakenhoff, E. DeGroot, and L. Aarden. 1988. Interleukin-6 is involved in interleukin-1-induced activities. Eur. J. Immunol. 18:957-959.
16. Mule, J.J., S.G. Marcus, J.C. Yang, J.S. Weber, and S.A. Rosenberg. 1992. Clinical application of IL-6 in cancer therapy. Res. Immunol. 143:777-779.
17. Elliott, M.J., R.N. Maini, and M. Feldmann. 1995. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumour necrosis alpha. Arthritis Rheum. 36:1681-1690.
18. Elliott, M.J., P. Woo, P. Charles, A. Long Fox, J.N. Woody, and R.N. Maini. 1997. Suppression of fever and the acute phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2). Br. J. Rheum. 36:589-593.
19. Wilson, A.G., J.A. Symons, T.L. McDowell, H.O. McDevitt, and G.W. Duff. 1997. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA. 94:3195-3199.
20. Angotti, E., E. Mele, F. Costanzo, and E.V. Avvedimento. 1994. A polymorphism (G→A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency. J. Biol. Chem. 269:17371-17374.
21. Danis, V.A., M. Millington, V.J. Hyland, and D. Grennan. 1995. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin. Exp. Rheumatol. 99:303-310.
22. McDowell, T.L., J.A. Symons, R. Ploski, O. Forre, and G.W. Duff. 1995. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum. 38:221-228.
23. Donn, R., A. Farham, J. Barren, W. Thomson, J. Worthington, and W. Ollier. 1998. IL1A is not associated with UK oligoarticular JCA. Br. J. Rheum. 37(Suppl. 1):38.
24. McGuire, W., A.V. Hill, C.E. Allsopp, B.M. Greenwood, and D. Kwiatkowski. 1994. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 371:508-510.
25. Cabrera, M., M.A. Shaw, C. Sharples, H. Williams, M. Castes, J. Convit, and J.M. Blackwell. 1995. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 182:1259-1264.
26. Roy, S., W. McGuire, C. Mascie-Taylor, B. Saha, S. Hazra, A. Hill, and D. Kwiatkowski. 1997. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J. Infect. Dis. 176:530-532.
27. Kunkel, L.M., K.D. Smith, S.H. Boyer, D.S. Borgaonkar, S.S. Wachtel, O.J. Miller, W.R. Breg, H.W. Jones, Jr., and J.M. Rary. 1977. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc. Natl. Acad. Sci. USA. 74:1245-1249.
28. Gould, M., S. Mohamed-Ali, S. Goubet, J. Yudkin, and A. Haines. 1993. Microalbuminuria: associations with height and sex in non-diabetic subjects. BMJ. 306:240-242.
29. Yudkin, J.S., C. Andres, V. Mohamed-Ali, M. Gould, A. Panahloo, A. P. Haines, S. Humphries, and P. Talmud. 1997. The angiotensin-converting enzyme gene and the angiotensin II type I receptor gene as candidate genes for microalbuminuria. A study in nondiabetic and non-insulin-dependent diabetic subjects. Arterioscler. Thromb. Vasc. Biol. 17:2188-2191.
30. Cruickshank, J.K., J. Cooper, J. MacDuff, and M. Burnett. 1991. Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet. 338:842-844.
31. Miller, S.A., D.D. Dykes, and H.F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
32. Orita, M., Y. Suzuki, T. Sekiya, and K. Hayashi. 1989. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 5:874-879.
33. Gudnason, V., Y.T. Mak, J. Betteridge, S.N. McCarthy, and S. Humphries. 1993. Use of the single-strand conformational polymorphism method to detect recurrent and novel polymorphisms in the low-density lipoprotein receptor gene in patients with familial hypercholesterolaemia: detection of a novel mutation Asp200 → TGly. Clin. Investig. 71:331-337.
34. Day, I.N., and S.E. Humphries. 1994. Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal. Biochem. 222:389-395.
35. Graham, F., and A. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:456-467.
36. Mohamed-Ali, V., S. Goodrick, A. Rawesh, J. Mile, D. Katz, J. Yudkin, and S. Coppack. 1997. Human subcutaneous adipose tissue releases IL6 but not TNF-alpha in vivo. J. Clin. Endocrinol. Metab. 82:4196-4200.
37. Yasukawa, K., T. Hirano, Y. Watanabe, K. Muratani, T. Matsuda, S. Nakai, and T. Kishimoto. 1987. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J. 6:2939-2945.
38. Hollon, T., and F.K. Yoshimura. 1989. Variation in enzymatic transient gene expression assays. Anal. Biochem. 182:411-418.
39. Bowcock, A.M., J.R. Kidd, G.M. Lathrop, L. Daneshvar, L.T. May, A. Ray, P.B. Sehgal, K.K. Kidd, and L.L. Cavalli Sforza. 1988. The human "interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics. 3:8-16.
40. Bowcock, A.M., A. Ray, H. Erlich, and P.B. Sehgal. 1989. Rapid detection and sequencing of alleles in the 3′ flanking region of the interleukin-6 gene. Nucleic Acids Res. 17:6855-6864.
41. Fugger, L., N. Morling, K. Bendtzen, L. Ryder, V. Andersen, C. Heilman, F. Karup Pedersen, J. Friis, P. Halbert, and A. Svejgaard. 1989. IL-6 gene polymorphism in rheumatoid arthritis, pauciarticular juvenile rheumatoid arthritis, systemic lupus erythematosus, and in healthy Danes. J. Immunogenet. 16:461-465.
42. Linker-Israeli, M., D.J. Wallace, J.L. Prehn, R. Nand, L. Li, and J.R. Klinenberg. 1996. A greater variability in the 3′ flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE). Autoimmunity. 23:199-209.
43. Murray, R., F. McGuigan, S. Grant, D. Reid, and S. Ralston. 1997. Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone. 21:89-92.
44. Ray, A., K.S. LaForge, and P.B. Sehgal. 1990. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol. Cell. biol. 10:5736-5746.
45. Liu, Y., H.U. Bernard, and D. Apt. 1997. NFI-B3, a novel transcriptional represser of the nuclear factor I family, is generated by alternative RNA processing. J. Biol. Chem. 272:10739-10745.
46. Rein, T., R. Forster, A. Krause, E.L. Winnacker, and H. Zorbas. 1995. Organization of the alpha-globin promoter and possible role of nuclear factor I in an alpha-globin-inducible and a noninducible cell line. J. Biol. Chem. 270: 19643-19650.
47. Murray, K., P. Donnelly, M. Passo, E. Giannini, and D. Glass. 1997. Windows of effect of disease associated HLA alleles in juvenile rheumatoid arthritis (Abstract). Arthritis Rheum. 40:S241.